Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 601.00
+1.00 (0.17%)
At close: Feb 2, 2026
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 38.74 billion as of January 30, 2026. Its market cap has increased by 731.62% in one year.
Market Cap
38.74B
Enterprise Value
38.55B
Revenue
29.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
601.00
Market Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 38.74B, an increase of 597.33%. That is a compound annual growth rate of 178.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 38.74B | 93.13% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 31.68B |
| Oneness Biotech | 31.48B |
| Lumosa Therapeutics | 29.57B |
| Polaris Group | 23.88B |
| Sunmax Biotechnology | 21.10B |
| EirGenix | 18.82B |
| TaiMed Biologics | 15.46B |
| AP Biosciences | 14.68B |